about
Activation of Rac1 by a Crk SH3-binding protein, DOCK180T cell regulation of p62(dok) (Dok1) association with Crk-LThe RAP1 guanine nucleotide exchange factor Epac2 couples cyclic AMP and Ras signals at the plasma membraneLocal activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizesOverexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cellsMembrane recruitment of DOCK180 by binding to PtdIns(3,4,5)P3A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activationHic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinaseFunction of the N-terminus of zizimin1: autoinhibition and membrane targeting.Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylationPhosphorylated guanine nucleotide exchange factor C3G, induced by pervanadate and Src family kinases localizes to the Golgi and subcortical actin cytoskeletonSignaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKLRequirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesisCrk activation of JNK via C3G and R-RasDedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development.Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.The C-terminal domain of Rac1 contains two motifs that control targeting and signaling specificity.c-Crk, a substrate of the insulin-like growth factor-1 receptor tyrosine kinase, functions as an early signal mediator in the adipocyte differentiation process.Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells.Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504.MOCA induces membrane spreading by activating Rac1.A PKC-SHP1 signaling axis desensitizes Fcγ receptor signaling by reducing the tyrosine phosphorylation of CBL and regulates FcγR mediated phagocytosis.Apoptotic cell and phagocyte interplay: recognition and consequences in different cell systems.Identification of targets of c-Src tyrosine kinase by chemical complementation and phosphoproteomicsFrontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysisSequential regulation of the small GTPase Rap1 in human platelets.GTK, a Src-related tyrosine kinase, induces nerve growth factor-independent neurite outgrowth in PC12 cells through activation of the Rap1 pathway. Relationship to Shb tyrosine phosphorylation and elevated levels of focal adhesion kinase.Dock8 interacts with Nck1 in mediating Schwann cell precursor migrationAll in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral.Src-CrkII-C3G-dependent activation of Rap1 switches growth hormone-stimulated p44/42 MAP kinase and JNK/SAPK activities.Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.Involvement of the c-Src-Crk-C3G-Rap1 signaling in the nectin-induced activation of Cdc42 and formation of adherens junctions.Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.
P2860
Q22007972-0DE078D5-F4DC-4041-BC8C-B4B06B375A10Q24291680-2FD6B3A7-56C9-4DEE-9637-744711BF673EQ24297422-7B9C91B7-95DA-474F-A6DC-4BB6EB875D0FQ24317534-E57BE6D6-5BDF-4BAA-86D2-E6D1F8E956B5Q24336373-E24A5290-B259-424F-989E-5E831B4D2BF2Q24532348-BBA1B91B-5D0D-4F06-91D4-34A5F3D56F52Q24535521-8B487DE7-C582-4D58-8380-66D05A9EE6CCQ24550885-3DC8C51E-EC69-4E0C-BFB8-1DB2324B2183Q24657963-0D770169-24F6-44BD-B2A1-EEAF846779F1Q24670296-75DAE630-1C73-4F65-9E43-7CA6C0C3CB04Q24804169-DC056AC3-C2E0-45B7-9E28-19A154A4F34FQ28141139-3084CA70-E3D4-492F-BBB1-81BD42DCDFF8Q28343294-0B59FB54-42FD-4B6F-8D37-B7CCC55B9A4CQ28609331-8D18ABAA-42F5-4E8A-931A-C79D6396446AQ30008878-06BBEAA9-126D-417D-B1A8-5E8BE34B69BAQ30155850-268DFD61-A9F6-47BC-A392-49015410E861Q30164617-A1FEA6FF-50A7-4FB7-8814-C01A13400177Q30168853-76099FE7-491D-46EF-8622-A190C4E610A3Q30476909-698DF7AA-A231-483E-A3A2-318EAC0E946EQ33861464-0DAB33CB-B6E5-410C-AE13-9B18EFA8F65BQ34289337-868E8BC5-5615-473E-8EA8-093101C19D62Q35179402-BAF64ACC-DDE2-4B72-982E-8B6EE71633E9Q35719265-D904F78D-050E-400F-8D83-2B9A0E2AED5CQ36144155-5F6404E0-3990-49FD-A206-D1F7418CE00CQ38611043-71083CB5-A808-44D8-9FBB-6E942E2BE142Q39450674-EBA4F43A-AAFA-4B96-B6E8-58C7BC67D798Q40870320-3803C362-316B-49F3-8130-09CDA2EE8628Q41683121-C739C945-E441-4DB0-9DE9-3671B3A68286Q42661182-5CB3E9E6-ED5E-4FDE-945E-4B7A7E2CB3BDQ42802113-EB3FF075-2785-49EE-99E5-70BC70A3624DQ42833900-043CB4C8-9891-4264-A670-D9427A5E2BD0Q45124238-A8C5FBF9-F09A-402C-8A22-B798DA78B387Q55055558-8669F84F-00EE-426B-9C1C-59AB78170002
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Role of Crk oncogene product in physiologic signaling.
@ast
Role of Crk oncogene product in physiologic signaling.
@en
type
label
Role of Crk oncogene product in physiologic signaling.
@ast
Role of Crk oncogene product in physiologic signaling.
@en
prefLabel
Role of Crk oncogene product in physiologic signaling.
@ast
Role of Crk oncogene product in physiologic signaling.
@en
P2093
P1476
Role of Crk oncogene product in physiologic signaling
@en
P2093
P304
P356
10.1615/CRITREVONCOG.V8.I4.30
P407
P577
1997-01-01T00:00:00Z